Preston Wendell  Wells net worth and biography

Preston Wells Biography and Net Worth

Vice President, Chief Financial Officer of Stryker

Preston Wells became Vice President, Chief Financial Officer in April 2025.

Preston is responsible for our global finance activities which include corporate accounting, reporting, tax, treasury and internal audit.

Upon joining Stryker in 2015, Preston began his career with our Spine Division, leading sales finance and sales operations. He then led Financial Planning and Analysis and Investor Relations for the company, and most recently took on the role of Vice President, Group Chief Financial Officer for our Orthopaedics and Spine Group.

Before joining Stryker, Preston had 17 years of experience as a senior accounting and financial management leader in global organizations. He was the CFO at Dialight Corporation and held various financial leadership positions within Johnson & Johnson.

Preston has a bachelor's degree in accounting from Bucknell University and an MBA in supply chain management from Lehigh University.

What is Preston Wendell Wells' net worth?

The estimated net worth of Preston Wendell Wells is at least $2.37 million as of November 20th, 2025. Mr. Wells owns 6,694 shares of Stryker stock worth more than $2,368,705 as of December 8th. This net worth evaluation does not reflect any other assets that Mr. Wells may own. Learn More about Preston Wendell Wells' net worth.

How do I contact Preston Wendell Wells?

The corporate mailing address for Mr. Wells and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Preston Wendell Wells' contact information.

Has Preston Wendell Wells been buying or selling shares of Stryker?

During the past quarter, Preston Wendell Wells has sold $60,370.20 in Stryker stock. Most recently, Preston Wendell Wells sold 165 shares of the business's stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $365.88, for a transaction totalling $60,370.20. Following the completion of the sale, the chief financial officer now directly owns 6,694 shares of the company's stock, valued at $2,449,200.72. Learn More on Preston Wendell Wells' trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (Chair and CEO), Viju Menon (Group President, Global Quality and Operations), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), Ronda Stryker (Director), and Preston Wells (Vice President, Chief Financial Officer). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 9 times. They sold a total of 1,126,468 shares worth more than $416,194,821.21. The most recent insider tranaction occured on November, 20th when CFO Preston Wendell Wells sold 165 shares worth more than $60,370.20. Insiders at Stryker own 5.2% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 11/20/2025.

Preston Wendell Wells Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2025Sell165$365.88$60,370.206,694View SEC Filing Icon  
See Full Table

Preston Wendell Wells Buying and Selling Activity at Stryker

This chart shows Preston Wendell Wells's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $352.71
Low: $353.01
High: $363.74

50 Day Range

MA: $368.34
Low: $353.42
High: $387.84

2 Week Range

Now: $352.71
Low: $329.16
High: $406.19

Volume

764,961 shs

Average Volume

1,445,912 shs

Market Capitalization

$134.88 billion

P/E Ratio

46.35

Dividend Yield

0.92%

Beta

0.89